Anti-Jo-1 antibody
An autoantibody linked to inflammatory muscle disease (myositis) and, importantly, to scarring of the lungs. A positive result in someone with muscle weakness or unexplained breathlessness points to the antisynthetase syndrome and prompts close monitoring of the lungs.
What it measures
Anti-Jo-1 is the most common of a family of autoantibodies (the antisynthetase antibodies) directed against enzymes that help build proteins — in this case histidyl-tRNA synthetase. It is measured when an autoimmune muscle disease is suspected, and it defines a distinctive clinical picture called the antisynthetase syndrome. The core features are an inflammatory muscle disease (myositis — polymyositis or dermatomyositis) causing muscle weakness, together with a strong tendency to interstitial lung disease (scarring and inflammation of the lungs), inflammatory arthritis, Raynaud's phenomenon, fever, and thickened cracked skin on the hands ('mechanic's hands'). Of these, the lung involvement is clinically the most important, because it drives outcome and needs monitoring and often treatment. A positive anti-Jo-1 therefore does two things: it supports the diagnosis of an autoimmune myositis, and it flags the person as being at high risk of lung disease, prompting lung function tests and imaging. Muscle enzymes such as creatine kinase are usually raised alongside it. It is a specialist antibody, interpreted by a rheumatologist or neurologist within the full picture; a negative result does not exclude myositis, as other myositis antibodies exist.
What a high value can mean
- Antisynthetase syndrome — the defining association; a positive result points to this specific pattern.
- Inflammatory muscle disease (polymyositis / dermatomyositis) — muscle weakness, usually with raised creatine kinase.
- Interstitial lung disease — the clinically most important complication; prompts lung monitoring.
- Inflammatory arthritis, Raynaud's, 'mechanic's hands', fever — other features of the syndrome.
What a low value can mean
- Negative — the expected result; but a negative does NOT exclude myositis, as other myositis-specific antibodies exist.
- Muscle enzymes and the clinical picture — are interpreted alongside, not the antibody alone.
When to discuss with a doctor
Anti-Jo-1 is tested when an autoimmune muscle disease is suspected — for example muscle weakness with raised muscle enzymes, or unexplained interstitial lung disease, sometimes with inflammatory arthritis, Raynaud's or the thickened 'mechanic's hands'. A positive result supports the diagnosis and, crucially, marks a high risk of lung involvement, so it prompts a specialist to arrange lung function tests and imaging and to plan treatment and monitoring. Because the lung disease can progress quietly, identifying the antibody matters for catching it early. The diagnosis and management are made by a rheumatologist or neurologist using the whole picture. Mediora.AI can surface a positive anti-Jo-1 alongside raised creatine kinase so the myositis pattern is visible in your results, but confirming the syndrome and monitoring the lungs belongs with your specialist team.